United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Buys Shares of 39,283 Centene Corporation $CNC

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund bought a new stake in Centene Corporation (NYSE:CNCFree Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund bought 39,283 shares of the company’s stock, valued at approximately $1,616,000.

A number of other institutional investors and hedge funds have also made changes to their positions in CNC. Addison Advisors LLC grew its position in shares of Centene by 455.6% during the third quarter. Addison Advisors LLC now owns 739 shares of the company’s stock worth $26,000 after buying an additional 606 shares in the last quarter. SBI Securities Co. Ltd. grew its position in shares of Centene by 118.4% during the fourth quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock worth $31,000 after buying an additional 406 shares in the last quarter. Ameriflex Group Inc. grew its position in shares of Centene by 152.5% during the third quarter. Ameriflex Group Inc. now owns 1,010 shares of the company’s stock worth $36,000 after buying an additional 610 shares in the last quarter. GoalVest Advisory LLC acquired a new position in shares of Centene during the fourth quarter worth about $37,000. Finally, Union Bancaire Privee UBP SA acquired a new position in shares of Centene during the fourth quarter worth about $37,000. 93.63% of the stock is owned by institutional investors and hedge funds.

Centene Price Performance

Shares of NYSE CNC opened at $59.72 on Friday. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.76. Centene Corporation has a twelve month low of $25.08 and a twelve month high of $60.76. The stock has a 50 day moving average of $45.44 and a two-hundred day moving average of $42.41. The stock has a market cap of $29.49 billion, a P/E ratio of -4.54, a P/E/G ratio of 0.46 and a beta of 1.06.

Centene (NYSE:CNCGet Free Report) last issued its quarterly earnings data on Tuesday, April 28th. The company reported $3.37 earnings per share for the quarter, beating analysts’ consensus estimates of $2.23 by $1.14. Centene had a positive return on equity of 5.57% and a negative net margin of 3.25%.The company had revenue of $49.94 billion during the quarter, compared to analysts’ expectations of $47.53 billion. During the same quarter in the previous year, the business earned $2.90 earnings per share. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. On average, research analysts forecast that Centene Corporation will post 3.45 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the company. Morgan Stanley boosted their price objective on Centene from $45.00 to $50.00 and gave the stock an “equal weight” rating in a research report on Wednesday, April 29th. Bank of America boosted their price objective on Centene from $60.00 to $72.00 and gave the stock a “buy” rating in a research report on Thursday, May 21st. Wells Fargo & Company boosted their target price on Centene from $44.00 to $56.00 and gave the stock an “equal weight” rating in a research note on Friday, May 1st. Jefferies Financial Group boosted their target price on Centene from $39.00 to $48.00 and gave the stock a “hold” rating in a research note on Wednesday, April 29th. Finally, Cantor Fitzgerald upgraded Centene from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $41.00 to $60.00 in a research note on Tuesday, April 28th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $58.18.

View Our Latest Report on Centene

Centene Company Profile

(Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.

Read More

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.